25 May 2013
Keywords: renovis, sciatica, drug, ren-1654, stalls, ph, ii
Article | 05 September 2005
California, USA-based drugmaker Renovis has reported disappointing results from a Phase II clinical trial studying REN-1654 in patients
with sciatica, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 September 2005
12 September 2005
24 May 2013
© 2013 thepharmaletter.com